Girish Putcha, PhD, MD

Girish currently serves as Principal at Precision Medicine & Diagnostics LLC, where he focuses on clinical, market access, regulatory, and policy strategy. He previously served as Chief Medical Officer, Senior Vice President of Reimbursement, and Clinical Laboratory Director at Freenome and as a member of CMS’ Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). Prior to that, as Director of Laboratory Science for Palmetto GBA’s MolDX program, Girish helped oversee coverage and reimbursement for molecular testing for its jurisdictions, representing over half of the Medicare population. He has also held senior leadership roles at Life Technologies (acquired by Thermo Fisher), Ariosa Diagnostics (acquired by Roche), and Crescendo Bioscience (acquired by Myriad). Prior to this, he focused on life science investments in biopharmaceuticals, medical devices, diagnostics and services at Panorama Capital and RiverVest Venture Partners, serving on the boards of several portfolio companies, including Presidio Pharmaceuticals, PowerVision, and Phenomix. 

Girish holds an MD and a PhD in molecular neuroscience from Washington University in St. Louis, with specialty training in clinical and molecular genetic pathology at Stanford University, where he also served as adjunct faculty.